China's Cardiovascular Devices Market to 2024: Rapid Technological Advances to Boost Market Growth - ResearchAndMarkets.com

The "China's
Cardiovascular Devices Market to 2024: Rapid Technological Advances to
Boost Market Growth" report has been added to ResearchAndMarkets.com's
offering.

The China cardiovascular devices market was valued at USD 2837.61
million in 2018, and it is expected to reach USD 4468.02 million by
2024, with an anticipated CAGR of 7.86% during the forecast period,
2019-2024.

The increasing incidence of cardiovascular diseases and the growing
geriatric population are the most significant factors driving the growth
of the market.

According to a report by the United Nation Economic and Social
Commission for Asia and the Pacific (ESCAP), the geriatric population in
the Asia-Pacific region was around 617.1 million in 2015, accounting for
more than half of the world's total elderly population. By 2050,
Asia-Pacific is estimated to account for almost two-thirds of the
world's geriatric population.

Furthermore, China's population is aging at a faster rate than almost
all other countries of the Asia-Pacific region, which is in part due to
the long run of China's one-child policy and the dramatic increase in
healthcare facilities. According to the government estimates, the
geriatric population may peak at more than 450 million geriatric
citizens, by 2050.

The aging process is commonly associated with increased vascular
rigidity and decreased vascular compliance. Elderly patients have a high
risk of developing cardiovascular disorders, such as peripheral arterial
disease (PAD), aortic disease, and venous thromboembolism (VTE). This is
primarily due to age-related alterations in vascular structure and
rigidity, further compounded by longer exposure to cardiovascular
disease (CVD) risk factors.

Furthermore, other factors, such as the rapid technological advances,
increasing awareness of the population, and high preference for
minimally-invasive procedures, are also supplementing the market growth.

ECG Dominated the Diagnostic and Monitoring Segment

On the diagnostic and monitoring front, the new generation of portable
and compact ECG are driving their greater adoption, especially in the
home healthcare segment. The rising awareness and demand for
minimally-invasive surgeries are driving the demand for coronary stents
and valves. Furthermore, increasing incidence rates of cardiovascular
diseases, such as arrhythmias, stroke, and high blood pressure, are
driving the demand for cardiac rhythm management devices, including
pacemakers and implantable defibrillators.

Competitive Landscape

Several local players, along with global medical device manufacturers.
operate in the Chinese market. Local players dominate in the stent,
catheter, and graft segments. However, the quality of products from
global companies is perceived as superior. Thus, the premium segment of
the cardiovascular devices market is dominated by global manufacturers.

Key Topics Covered

1 INTRODUCTION

1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

4.1 Market Overview

4.2 Market Drivers

4.2.1 Rapid Technological Advances to Boost the Market Growth

4.2.2 Increasing Awareness among the Population

4.2.3 Increased Preference of Minimally-invasive Procedures

4.3 Market Restraints

4.3.1 Stringent Regulatory Policies

4.3.2 High Cost of Instruments and Procedures

4.4 Porter's Five Forces Analysis

5 MARKET SEGMENTATION

5.1 By Device Type

5.1.1 Diagnostic and Monitoring Devices

5.1.1.1 Electrocardiogram (ECG)

5.1.1.2 Remote Cardiac Monitoring

5.1.1.3 Other Diagnostic and Monitoring Devices

5.1.2 Therapeutic and Surgical Devices

5.1.2.1 Cardiac Assist Devices

5.1.2.2 Cardiac Rhythm Management Device

5.1.2.3 Catheter

5.1.2.4 Grafts

5.1.2.5 Heart Valves

5.1.2.6 Stents

5.1.2.7 Other Therapeutic and Surgical Devices

6 COMPETITIVE LANDSCAPE

6.1 Company Profiles

6.1.1 Abbott Vascular

6.1.2 Boston Scientific Corporation

6.1.3 Mindray Medical International Limited

6.1.4 Edwards Life Sciences

6.1.5 W.L. Gore & Associates Inc.

6.1.6 Medtronic PLC

6.1.7 Biotronik Inc.

6.1.8 Lepu Medical Technology (Beijing) Co. Ltd.

6.1.9 Terumo Corporation

6.1.10 Microport Scientific Corporation

6.1.11 Getinge Group (Maquet Holding B.V. & Co. KG)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/ywpyka

View source version on businesswire.com: https://www.businesswire.com/news/home/20190523005369/en/